In situ hybridization using antisense RNA probes was used t o localize cells that produce erythropoietin (EPO) in the livers of anemic transgenic mice expressing the human EPO gene and in livers of anemic nontransgenic mice. In transgenic mice bled from a hematocrit of 55% to one of 10%. hepatocytes surrounding central veins synthesized large amounts of human EPO mRNA. EPO-producing cells were very rare in the area of portal triads. In transgenic mice bled t o a hematocrit of 20%. a similar number and distribution of cells contained human EPO mRNA as was found with a 10% hematocrit, but the cells were less heavily labeled, indicating increased EPO production per cell at 10% hematocrit as compared with 20% hematocrit. No human EPO mRNA was detected in the kidneys of anemic transgenic mice, although endogenous murine EPO mRNA was strongly expressed in cortical intersti-IDNEY AND LIVER are the only organs known to K produce erythropoietin (EPO) in adult mammals. '-5 In adult mice, the kidneys account for approximately 90% of total EPO production.6 Peritubular interstitial cells in the cortex and outer medulla synthesize EP0,7,8 but EPOproducing cells represent only a small subset of the total interstitial cell population' and their origin is unknown. The cells are small with little cytoplasm visible by light microscopy7,* and appear to produce EPO in an all-or-none fashion, with the number of cells producing EPO being inversely related to hematocrit.' In contrast to the kidney, little is known about cells that synthesize EPO in the liver.
In situ hybridization using antisense RNA probes was used t o localize cells that produce erythropoietin (EPO) in the livers of anemic transgenic mice expressing the human EPO gene and in livers of anemic nontransgenic mice. In transgenic mice bled from a hematocrit of 55% to one of 10%. hepatocytes surrounding central veins synthesized large amounts of human EPO mRNA. EPO-producing cells were very rare in the area of portal triads. In transgenic mice bled t o a hematocrit of 20%. a similar number and distribution of cells contained human EPO mRNA as was found with a 10% hematocrit, but the cells were less heavily labeled, indicating increased EPO production per cell at 10% hematocrit as compared with 20% hematocrit. No human EPO mRNA was detected in the kidneys of anemic transgenic mice, although endogenous murine EPO mRNA was strongly expressed in cortical intersti-IDNEY AND LIVER are the only organs known to K produce erythropoietin (EPO) in adult mammals. '-5 In adult mice, the kidneys account for approximately 90% of total EPO production.6 Peritubular interstitial cells in the cortex and outer medulla synthesize EP0,7,8 but EPOproducing cells represent only a small subset of the total interstitial cell population' and their origin is unknown. The cells are small with little cytoplasm visible by light microscopy7,* and appear to produce EPO in an all-or-none fashion, with the number of cells producing EPO being inversely related to hematocrit.' In contrast to the kidney, little is known about cells that synthesize EPO in the liver.
In the current study, we use in situ hybridization to determine the location of EPO-producing cells within liver sections from anemic transgenic and nontransgenic mice. Previous analyses of human EPO mRNA expression have been performed on transgenic mice which carry a 10-kb fragment of human genomic DNA encompassing the intact human EPO gene with 0.7 kb of 3'-flanking sequence and 6 kb of 5'-flanking sequence." When these transgenic mice are made anemic by bleeding or are treated with cobalt chloride, the human EPO gene is strongly expressed in the liver but not in the kidney or any other organ tested." Thus, the 10-kb DNA fragment contains regulatory elements that permit liver-specific expression of the EPO gene. The level of expression is supranormal in that it greatly exceeds the expression of the endogenous murine EPO gene in liver. Because the specificity of gene expression is believed to result from the interaction of trans-acting factors with cis-acting DNA sequences, the regulated hepatic expression of the transgene implies that it is being expressed in cells responsible for murine EPO production. Furthermore, expression of the transgene at supranormal levels relative to the endogenous gene should facilitate localization of EPO-producing cells in the liver.
MATERIALS AND METHODS
Probes for in situ hybridization. The 2,125-bp BamHI-Sma I murine EPO gene fragment has been characterized by in situ hybridi~ation,'.~ Northern blot analysis," and RNase protection assay.637 The fragment was cloned into pGEM 1 (Promega Biotec, tial cells. In sections of livers from nontransgenic mice bled from a hematocrit of 45% to one of IO%, only isolated cells produced EPO. When the types of cells could clearly be identified, approximately 80% of these cells were hepatocytes, while 20% had a nonepithelial morphology and were located in or adjacent t o the sinusoidal spaces. When the sense strand was used as the RNA probe for in situ hybridization, no labeled cells were seen in normal or anemic livers. These results demonstrate that hepatocytes are responsible for production of €PO in both transgenic and nontransgenic mice and that a second cell type that is similar in morphology t o EPO-producing interstitial cells in the kidney also pro- Transgenic mice used in this study were from the Tg118 line previously described." These mice carry six tandem copies of a 10-kb human genomic DNA fragment that consists of 0.7 kb of 3'-flanking sequence, the human EPO gene, and 6 kb of 5'-flanking sequence. Heterozygous mice were intercrossed and homozygous transgenic mice identified by gene dosage densitometry.'* Homozygous mice were bred to generate litters of homozygous transgenic mice. Three homozygous transgenic littermates were analyzed in this study. C)ccanriruriim i~fE/'t>-pw/itcing rds. The total numher. numher p r unit wca. and typcsof cclls prtducing EPO mRNA in the liven of nnntmnspenic micc wcrc c1urntii;ited ;I S fnllnws. Cclls containing EPO mRNA in each livcr section on the slidc wcre cnunted using a 40x crhjcctive. Aftcr counting. the slicla wcrc pmjcctcil at a linal magniliciition of I l x and the outlincs of the livcr tissue wcrc traced onto papr. The arca of each sectinn of liver wasdetermined hy cutting and weighing. Results werc cxprcsscd as the numhcr of EW-prcducing cells pcr quam ccntimctcr nf liver section. I n the prescnt study. I I mcasurcmcnts nn separate reclions fmm diffcrcnt arcas of liver wcrc uscil to determine the mean and standard dcviation for a sin& nnntr;insgenic mnuse and cnmparcd with a nnnancmic mntrnl. A. cclls wcrc cnuntctl. they werc c;ite@orixcd as k i n g cpithclial. nonepit helial. or of indeterminate mnrpholcw.
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RESULTS
EPO
Tn clctcrminc the types of cclls producing EPO in the Iransgcnic mite. phntomicmpr;iphs wcrc taken of I I CPt E stained in situ autorailicvr;ims of livcrs fmm micc hlcd to a hematncrit of IOV.
Slides mre then destained using acid alcohol. stained with PAS. and the same arcas were photomicmpraphed again. The Rvo setsof photomicqraphs wcrc mmparcd. and thc EfW-pmducing cells were cateprixcd as k i n g epithelial or nnncpithclial. nontransgenic mice.6v11 Thus, the endogenous murine EPO gene in the transgenic mice is expressed normally, ie, to a much greater extent in kidney than liver. In contrast, the human EPO gene is expressed specifically in the liver and to much higher levels than the endogenous mouse EPO gene."
Localization of cells producing human EPO mRNA in transgenic mice. Figure 2A is a low-magnification photomicrograph of an in situ autoradiogram of a liver section taken from a transgenic mouse. The mouse was bled to a hematocrit of 10% and hybridized with the human EPO cRNA probe. Figure 2B is a photomicrograph of the same area after removal of silver grains from the emulsion and restaining of the section with PAS. In Fig 2A, the distribution of cells producing human EPO mRNA is not random. Silver grain density is greatest over cells surrounding the central vein (CV), whereas grain density is least over cells surrounding portal areas. Portal areas (PA) contain a branch of the portal vein, a branch of the hepatic artery, and a bile duct, and therefore are easily distinguished from central veins that do not have companion structures. Figure  2B more clearly demonstrates the difference in morphology between the portal area and central vein shown in Fig 2A . Figure 2C is a higher-magnification photomicrograph of some of the human EPO-producing cells around the central vein shown in Fig 2A. In Fig 2C, cells surrounding the central vein are heterogeneous with respect to the density of silver grains. Figure 2D is the same area shown in Fig 2C after removal of the silver grains and PAS staining. The arrowheads indicate the cells that were heavily overlaid with silver grains in Figure 2C . Each of the cells indicated is a hepatocyte, and the heavy accumulation of grains is associated with the nucleus. In less heavily labeled cells, the distribution of silver grains is more uniform throughout the cell. We are unsure as to why EPO mRNA is preferentially associated with the nucleus or perinuclear region of the cells. We did not observe any cells with a nonepithelial morphology that hybridized with the human cRNA probe.
We next examined whether the production of human EPO mRNA that occurred in transgenic mice as their hematocrits were lowered from 55% to 10% (see Fig 1, top) was due to recruitment of human EPO-producing cells or due to increased production of human EPO mRNA by individual cells. We performed in situ hybridization on sections of liver from transgenic littermates that were unbled or bled to hematocrits of either 20% or 10%. To make comparisons between livers from transgenic mice at each of these hematocrits, sections from each were placed on the same slide and carried through the in situ hybridization protocol together as described in Materials and Methods. Figure 2E demonstrates the silver grain density over human EPO-producing cells in liver of the transgenic mouse bled to a hematocrit of 10%. The silver grain density is as described above, ie, greatest over cells surrounding the central vein and lowest in the portal area. Figure 2F demonstrates the silver grain density over human EPOproducing cells in the liver of a transgenic littermate bled to a hematocrit of 20%. The number of cells with an increased grain density is similar to that at the 10% hematocrit. In the mice with 20% hematocrit, the density of silver grains is still greatest over cells surrounding the central vein and least in the portal area, but the density of silver grains over individual cells is not as great at 20% hematocrit as compared with 10%. In the section taken from the unbled sibling (hematocrit 55%), the silver grain density is uniformly low in all areas (Fig 2G) and represents background.
Localization of cellsproducing EPO mRNA in the livers of nontransgenic mice. In situ hybridization was performed using the murine cRNA probe to localize cells producing EPO mRNA in the livers of nontransgenic mice. In contrast to the results obtained with transgenic mice, EPOproducing cells were rare in nontransgenic mice. However, cells that exhibited specific hybridization were clearly identified. The density of EPO-producing cells increased 40-fold in the liver of a nontransgenic mouse bled to a hematocrit of 10% as compared with a nonbled control with a hematocrit of 45% (Table 1) .
Two types of cells produced EPO in the livers of nontransgenic mice. As in the case of the transgenic mice, hepatocytes produced EPO in nontransgenic mice (cells 1 and 3 in Fig 3, A through D) . Silver grains were preferentially associated with the nucleus of EPO-producing hepatocytes in severely anemic nontransgenic mice, as was reported above for transgenic mice bled to a hematocrit of 10%. In addition to hepatocytes, a population of small, nonepithelial cells found in or adjacent to sinusoids also produced EPO mRNA in nontransgenic mice (cell 2 in Fig  3, A, B , E, and F). The nonepithelial cells were morphologically similar to EPO-producing interstitial cells in the renal cortex in that they had small, relatively dense nuclei and little visible cytoplasm. The relative proportions of each of these cell types as determined from H & E stained sections from different areas of liver from a nontransgenic mouse are summarized in Table 1 . Although the number of each type of cell was quantitated in a single mouse, both hepatocytes and nonepithelial cells have been observed to produce EPO mRNA in multiple in situ hybridization experiments using several severely anemic nontransgenic mice.
When sense strand RNAwas used in the in situ hybridization experiments, only scattered background grains were seen in either anemic or nonanemic livers (data not shown). Kidneys from the anemic, nontransgenic mice (which were processed for in situ hybridization in the same sections as their corresponding liver) contained cells in the interstitium between tubules that were heavily covered with silver grains as previously described.7s9 In nontransgenic mice, the kidney interstitial cells appeared to contain more EPO mRNA than EPO-producing cells in sections of liver from the same animal because the kidney interstitial cells were detectable after shorter exposure times of the in situ autoradiograms.
DISCUSSION
These in situ hybridization studies demonstrate that hepatocytes express human EPO mRNA in transgenic mice. The EPO-producing hepatocytes are found preferentially in the areas surrounding central veins. One explanation for this pattern of distribution may be the result of *Mean .)-SD. tData are from 11 sections examined from different areas of liver from an anemic mouse and from six sections examined from different areas of liver from a nonanemic mouse. Sections from anemic and nonanemic mice were on the same slides as described in Materials and Methods.
blood flow patterns within the liver. The portal vein carries blood that has passed through capillary beds in the gut and, thus, is at least partially oxygen depleted. Blood from the portal vein mixes with arterial blood from the hepatic artery in the region of the portal triad, then it percolates through the venous sinusoids surrounding the hepatic cords, and finally it flows into the central veins. Because hepatocytes extract oxygen from the blood during its passage through the sinusoids, an oxygen gradient exists between the portal triad and central vein, with the areas of highest oxygen availability being nearest the portal triad." When the hematocrit of the transgenic mouse is lowered to 20%, the oxygen-carrying capacity of the blood is decreased such that hepatocytes around the central veins become sufficiently hypoxic to induce the expression of the human EPO transgene. A further reduction of the hematocrit to 10% results in a greater degree of hypoxia sensed in the centrilobular hepatocytes, inducing the cells to produce more human EPO mRNA. In this severely anemic situation, the oxygen available in the portal areas is still sufficient to prevent the hepatocytes in this area from reaching their threshold for expression of the human EPO transgene.
An alternative, but not mutually exclusive, explanation for the centrilobular pattern of expression observed in the transgenic mice is that the centrilobular hepatocytes are specialized at the molecular level such that they can sense hypoxia and respond by producing EPO, while those hepatocytes in the portal areas lack the ability to respond to hypoxia. Support for the idea that centrilobular hepatocytes represent a specialized cell type comes from numerous studies that have described a zonal heterogeneity of hepatocytes."
While it cannot be excluded that some additional epithelial cells are recruited to produce human EPO mRNA in the transgenic mice in response to lowering the hematocrit to 10% as opposed to 20%, it is clearly evident that individual cells produce more human EPO mRNA at a hematocrit of 10% than at 20% when comparing the density of silver grains over individual cells in in situ autoradiograms. In contrast, we have found that in anemic, nontransgenic murine kidney interstitial cells are induced to produce EPO in an all-or-none pattern, and as anemia becomes more severe more cells are recruited to produce EP0. 9 These results suggest that different regulatory mechanisms control the response of EPO-producing cells to hypoxia in the transgenic liver and in the nontransgenic kidney.
When in situ hybridization was performed on kidneys from severely anemic transgenic mice, no specific hybridization was observed using the human EPO cRNA probe, but when the murine EPO cRNA probe was used for hybridization on sections of the same kidney, interstitial cells in the cortex were seen to contain EPO mRNA (not shown). Conversely, when the murine EPO cRNA probe was used on liver sections of severely anemic transgenic mice, only isolated cells produced murine EPO mRNA, even though human EPO mRNA was heavily expressed as described above (not shown). These results show that the mouse and human EPO cRNA probes used exhibited complete specificity for human or mouse EPO mRNA, respectively. Furthermore, the results show that expression of the endogenous mouse EPO gene is normal in transgenic mice and is independent of expression of the human transgene.
Eight independently derived lines of transgenic mice carrying the human EPO gene with either 0.4 kb or 6 kb of 5'-flanking sequence exhibit inducible expression in liver," indicating that inducibility in the liver is an inherent property of the transgene, which is not dependent on the integration site within the mouse genome. However, in humans extrarenal EPO synthesis apparently cannot compensate for the loss of renal EPO production during the anemia of chronic renal failure. These observations are consistent with a model in which human EPO gene expression is repressed in adult liver through a negativeregulatory element that is not included within the previously described transgenic constructs. Other transgenic mice carrying additional flanking sequences are presently being generated to test this hypothesis.
In nontransgenic mice, the endogenous murine EPO gene is not induced in liver unless mice are made severely anemic and the level of expression is much less than that of the human EPO transgene. Both hepatocytes and nonepithelia1 cells synthesize murine EPO mRNA in sections of liver from severely anemic nontransgenic mice. The nonepithelial cells represent only about 20% of the total number of EPO-producing cells in the sections. The nonepithelial cells are morphologically similar to the interstitial cells that produce EPO in the renal c~r t e x .~-~ However, the nonepithelial cells in the liver produced less EPO mRNA than the will b e necessary to answer these questions.
